ClinicalTrialsFinder

Relapsed Ovarian Cancer Clinical Trials in Hangzhou, Zhejiang

1 recruitingHangzhou, Zhejiang, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial

Relapsed Ovarian Cancer
Women's Hospital School Of Medicine Zhejiang University400 enrolled1 locationNCT05607329